Make your own free website on Tripod.com
Layout
Oncology (Anti Cancer Injectables) :

    We offer a wide range of high quality pharmaceutical injectables, anti cancer injectables for the treatment of cancer. Developed after intensive research, these are superior in quality, performance and the capacity to decrease the capacity of spreading cancer cells subsequently. We are capable to cater to the bulk requirements of our clients. Given below is a list of the anti cancer injectables offered by us.
  • Cisplatin Injection
  • Carboplatin Injection
  • Doxorubicin Injection
  • Docetaxel Injection
  • Epirubicin Injection
  • Etoposide Injection
  • Granisetron Injection
  • Amifostine Injection
  • Paclitaxel Injection
  • Oxaliplatin Injection
  • Bleomycin Injection
  • Cytarabine Injection
  • Cyclophosamide Injection
  • Paclitaxel Injection
  • Cytosine Arabinoside Injection
  • Di-Sodium Pamidronate Injection
  • Dacarbazine Injection
  • Dactinomycin Injection
  • Daunorubicin Injection
  • Fludarabine Injection
  • Gemcitabine Injection
  • Irinotecan Injection
  • Ifosfamide Injection
  • Leuprolide Injection
  • L-Asparaginase Injection
  • Methotrexate Injection
  • Mesna Injection
  • Mitoxantrone Injection
  • Topotecan Injection
  • Vincristine Injection
  • Vinorelbine Injection
  • Vinblastine Injection
  • Zolendronic Acid

Marketing is redefined with
informative and innovative
professionals with people
focus
Bulk Drug Manufacturing
industry made itsstunning
heights with Lividus
pharma..
+91 - 4761234567
News and Events



  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

Home  |  Manufacturing  |  Products  |  Careers  |  Contact